Brief Article
Copyright ©2009 The WJG Press and Baishideng.
World J Gastroenterol. Nov 21, 2009; 15(43): 5449-5454
Published online Nov 21, 2009. doi: 10.3748/wjg.15.5449
Table 1 Baseline characteristics of patients at enrolment
Sex (M/F)46/22
Age, median (range)59 (22-68)
BMI, median (range)24.2 (15.5-40.5)
Months since LT, median (range)15.5 (1-151)
Previous acute cellular rejection n (%)13 (19)
Days since OLT, mean36.4
Previous CMV infection n (%)14 (21)
Genotype n (%)
153 (76.5)
26 (9)
34 (6)
45 (7)
Viral load (MEq/mL), median (range)10.6 (0.009-40)
ALT (IU/L), median (range)136 (52-945)
Neutrophil count (× 103/mmc) mean ± SD3 ± 1.2
Hemoglobin (g/dL) mean ± SD12.9 ± 1.5
Cirrhosis n (%)10 (15)
Pre-LT antiviral treatment n (%)29 (45)
Post-LT antiviral treatment n (%)15 (22)
Induction immunosuppression n (%)
Monoclonal antibodies10 (14)
Steroids49 (72)
Other3 (4)
NA6 (10)
Maintenance immunosuppression n (%)
Cyclosporine30 (44)
Tacrolimus22 (32)
Cyclosporine + steroids6 (9)
Tacrolimus + steroids9 (13)
Other1 (1.5)